Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hale

Showing results (461-470 of 521) with videos related to

Pageof 53
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I studyG L Phillips, B Meisenberg, D E Reece, et al.
The Lancet. Oncology|October 3, 2006
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialAmar Gajjar, Murali Chintagumpala, David Ashley, et al.
Blood|April 18, 1998
Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study GroupC Peters, E G Shapiro, J Anderson, et al.
American Journal of Public Health|December 22, 2017
Impact of Dual Use of Department of Veterans Affairs and Medicare Part D Drug Benefits on Potentially Unsafe Opioid UseWalid F Gellad, Joshua M Thorpe, Xinhua Zhao, et al.
Bone Marrow Transplantation|September 5, 2017
Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms' tumor: a CIBMTR retrospective analysisM H Malogolowkin, M T Hemmer, J Le-Rademacher, et al.
Bone Marrow Transplantation|March 29, 2011
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDSS M Luger, O Ringdén, M-J Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplantSonali M Smith, Koen van Besien, Jeanette Carreras, et al.
ACS Chemical Biology|February 20, 2026
Modified Polycyclic Compounds Rescue Mis-splicing in Myotonic Dystrophy Type 1 Disease ModelsJesus A Frias, Sawyer M Hicks, Hormoz Mazdiyasni, et al.
Bone Marrow Transplantation|June 24, 2014
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1K Fleischhauer, M A Fernandez-Viña, T Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 7, 2014
Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescentsXiaxin Li, Ruta Brazauskas, Zhiwei Wang, et al.
Pageof 53

Showing results (461-470 of 521) with videos related to

Sort By:
Pageof 53
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 19, 2004
Amifostine and autologous hematopoietic stem cell support of escalating-dose melphalan: a phase I studyG L Phillips, B Meisenberg, D E Reece, et al.
The Lancet. Oncology|October 3, 2006
Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trialAmar Gajjar, Murali Chintagumpala, David Ashley, et al.
Blood|April 18, 1998
Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study GroupC Peters, E G Shapiro, J Anderson, et al.
American Journal of Public Health|December 22, 2017
Impact of Dual Use of Department of Veterans Affairs and Medicare Part D Drug Benefits on Potentially Unsafe Opioid UseWalid F Gellad, Joshua M Thorpe, Xinhua Zhao, et al.
Bone Marrow Transplantation|September 5, 2017
Outcomes following autologous hematopoietic stem cell transplant for patients with relapsed Wilms' tumor: a CIBMTR retrospective analysisM H Malogolowkin, M T Hemmer, J Le-Rademacher, et al.
Bone Marrow Transplantation|March 29, 2011
Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDSS M Luger, O Ringdén, M-J Zhang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplantSonali M Smith, Koen van Besien, Jeanette Carreras, et al.
ACS Chemical Biology|February 20, 2026
Modified Polycyclic Compounds Rescue Mis-splicing in Myotonic Dystrophy Type 1 Disease ModelsJesus A Frias, Sawyer M Hicks, Hormoz Mazdiyasni, et al.
Bone Marrow Transplantation|June 24, 2014
Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1K Fleischhauer, M A Fernandez-Viña, T Wang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 7, 2014
Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescentsXiaxin Li, Ruta Brazauskas, Zhiwei Wang, et al.
Pageof 53